Other Capital Market Information | 30 March 2020 17:42

Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052
30.03.2020 / 17:42
Dissemination of a Post-admission Duties announcement transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

– Share buy-back – 41 ^st Interim Report

In the period from March 23, 2020 until and including March 27, 2020, a total of 2,985,306 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA (‘Fresenius Medical Care’) announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange and via selected multilateral trading facilities (MTF):

XETRA

Day of repurchase	Aggregated volume in number of shares	Weighted average share price in EUR
23.03.2020	354,067	55.6526
24.03.2020	423,889	56.4566
25.03.2020	484,813	55.9871
26.03.2020	499,539	57.0763
27.03.2020	511,629	57.3918

Chi-X Europe

Day of repurchase	Aggregated volume in number of shares	Weighted average share price in EUR
23.03.2020	83,000	55.7166
24.03.2020	85,572	56.2945
25.03.2020	90,000	55.9076
26.03.2020	94,572	57.0598
27.03.2020	99,576	57.3779

BATS Europe

Day of repurchase	Aggregated volume in number of shares	Weighted average share price in EUR
23.03.2020	15,481	55.5304
24.03.2020	15,382	56.3401
25.03.2020	19,890	55.8949
26.03.2020	83,072	57.1051
27.03.2020	29,996	57.3063

Turquoise

Day of repurchase	Aggregated volume in number of shares	Weighted average share price in EUR
23.03.2020	17,634	55.5915
24.03.2020	13,783	56.3085
25.03.2020	16,470	56.0811
26.03.2020	22,000	57.0759
27.03.2020	24,941	57.3308

The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including March 27, 2020 therefore amounts to 8,888,355 shares.

Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care’s website at www.freseniusmedicalcare.com under section Investors.

Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board

Bad Homburg v.d.H., March 30, 2020

30.03.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language:	English
Company:	Fresenius Medical Care AG & Co. KGaA
	Else-Kröner-Straße 1
	61352 Bad Homburg
	Germany
Internet:	www.freseniusmedicalcare.com

End of News DGAP News Service